Exagen Inc. (NASDAQ: XGN) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT EXAGEN INC.

Exagen Inc. (NASDAQ: XGN)
Listen to this Section


$4.37
-0.4200 ( -8.77% ) 173.2K

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Market Data


Open $4.37
Previous Close $4.79
Volume 173.2K
Market Cap $109.69M
Day Range $4.20 - $4.85
52 Week Range $2.59 - $12.23
Shares Outstanding 24.16M
Change % -8.77%
Net Change ▼ -0.4200
Insider Ownership -0.04%
Exchange NASDAQ
SectorHealthcare
IndustryMedical Specialities
IPO Year2019
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -287,957.00

Date Type Amount Purchased Purchaser
2024-02-22 Sale -75000.00 Adawi Kamal
2024-02-22 Sale -175000.00 ABALLI JOHN
2024-02-08 Sale -6738.00 Adawi Kamal
2023-10-18 Sale -33819.00 ABALLI JOHN
2023-09-06 Sale -9803.00 ABALLI JOHN

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 66 Nov 04, 2025
8-k 8K-related 14 Nov 04, 2025
4 Insider transactions 1 Oct 20, 2025
4 Insider transactions 1 Sep 04, 2025
8-k 8K-related 14 Jul 29, 2025
10-q Quarterly Reports 67 Jul 29, 2025
8-k 8K-related 14 Jul 17, 2025
4 Insider transactions 1 Jun 12, 2025
4 Insider transactions 1 Jun 12, 2025
4/a Other 1 Jun 12, 2025

Latest News


× Before browsing our site, please accept our cookies policy